Keymed and Lepu Biopharma Jointly Announces Global Exclusive Licence Agreement with Astrazeneca for Cmg901
ownership).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.16 HKD | +15.44% | +15.18% | +22.57% |
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,190 GBX | +1.35% | -0.86% | 240B | ||
32.2 HKD | +1.58% | -5.71% | 1.14B | ||
5.16 HKD | +15.44% | +15.18% | 1.13B | ||
1st Jan change | Capi. | |
---|---|---|
+22.57% | 1.13B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |